MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to vaccinex,...
-$5,732K
Income (loss) from
continuing operations...
-$5,732K
Operating income (loss)
-$4,552K
Loss on settlement of
warrants
-$1,106K
Change in fair value of
warrant liabilities
$71K
Other nonoperating
income (expense)
-$3K
Revenue from contract
with customer,...
$52K
Costs and expenses
$4,604K
Research and development
expense
$3,165K
General and
administrative expense
$1,439K
Back
Back
Income Statement
source: myfinsight.com
VACCINEX, INC. (VCNX)
VACCINEX, INC. (VCNX)